CTOs on the Move


 
uBiome is the leading microbial genomics company. We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

uBiome raised $26.62M on 11/02/2016
uBiome raised $83M on 09/21/2018

Similar Companies

American Pathology Partners

American Pathology Partners (AP2) company career center! We appreciate your interest in career opportunities with us and encourage you to explore our site to learn more about us and our partner laboratories in Colorado (UniPath), Florida (Palm Beach Pathology), North Carolina (Eastern Carolina Pathology). We are committed to building long-term partnerships within the communities we serve through service excellence and our commitment to the latest in technological innovation. Our pathologist partners are valued leaders within our affiliated laboratories and deliver specialized anatomic and molecular pathology services within their local and regional healthcare markets. As a growing organization, we offer a diversity of laboratory positions in histology, grossing, flow cytometry, cytology processing, molecular as well as career opportunities in finance, sales, information technology and human resources. We offer a competitive salary and excellent benefits package including Medical, Dental, Vision, Life, Long-Term Disability, Flexible Spending Accounts, and a Tuition Reimbursement Program. In addition, we support ongoing educational programs and career opportunities; provide liberal Paid Time Off benefits; and offer a generous Retirement 401(k) plan.

Technology and Patent Research International

Technology and Patent Research International is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MINT dentistry

MINT dentistry is the fastest growing privately-owned and innovative dental practice in the United States. We hire only the most talented artists – true Cosmetic Dentists – and then train them to Mint`s exacting standards. MINT dentists have been named “Best Dentist in Dallas,” and “Best Dentist in Houston” by the International Academy of Elite Cosmetic Dentistry the last two years, named “Best Family Dentists” by Consumer`s Choice the last two years, recognized by Living Magazine as “Outstanding Dentists”, recognized by Modern Luxury Dallas and Modern Luxury Houston as “Elite Doctors” and have garnered numerous other accolades from countless other sources. MINT dentistry took the industry over with our expertise in General and Cosmetic dentistry. The year after MINT opened, Dr. Harrison, the founder and CEO, invented a procedure to lengthen teeth in conjunction with veneers (lengthening teeth is needed for patients with short teeth, gingiva overgrowth, or smiles with too much gum showing). After revolutionizing Cosmetic Dentistry, we then reexamined every technique in General Dentistry, which is very technique sensitive. We questioned everything, and tried every material and technique on the market because we wanted our patients to have the best. As Mint grew, we focused on reducing complication rates. Most dental offices strive to achieve a 10% complication rate. Mint has succeeded in achieving a 1/1000th complication rate by developing the Mint Standards of Dentistry. These Standards specify our materials and our new techniques that we train dentists to use (it`s our secret sauce). Mint offers you dentists who work as a team (we invented this as well), extraordinary prices, and an insurance department that handles everything. Plus incredible payment plans and industry changing techniques. All this to be said you have to experience MINT dentistry to appreciate it, because it`s like nothing you`ve ever experienced.

vision orlando inc

vision orlando inc is a Winter Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Afferent Pharmaceuticals

Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.